Mercer Global Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.25M | Buy |
18,523
+3,462
| +23% | +$1.54M | 0.02% | 413 |
|
2025
Q1 | $7.3M | Buy |
15,061
+1,053
| +8% | +$511K | 0.02% | 449 |
|
2024
Q4 | $5.64M | Sell |
14,008
-1,543
| -10% | -$621K | 0.01% | 512 |
|
2024
Q3 | $7.3M | Sell |
15,551
-952
| -6% | -$447K | 0.02% | 399 |
|
2024
Q2 | $7.7M | Buy |
16,503
+3,106
| +23% | +$1.45M | 0.02% | 358 |
|
2024
Q1 | $5.6M | Sell |
13,397
-1,119
| -8% | -$468K | 0.02% | 433 |
|
2023
Q4 | $5.91M | Buy |
14,516
+2,789
| +24% | +$1.13M | 0.02% | 421 |
|
2023
Q3 | $4.08M | Buy |
11,727
+713
| +6% | +$248K | 0.02% | 486 |
|
2023
Q2 | $3.88M | Buy |
11,014
+899
| +9% | +$316K | 0.02% | 519 |
|
2023
Q1 | $3.19M | Buy |
10,115
+1,821
| +22% | +$574K | 0.01% | 553 |
|
2022
Q4 | $2.4M | Buy |
8,294
+170
| +2% | +$49.1K | 0.01% | 648 |
|
2022
Q3 | $2.35M | Sell |
8,124
-835
| -9% | -$242K | 0.01% | 590 |
|
2022
Q2 | $2.53M | Sell |
8,959
-1,127
| -11% | -$318K | 0.02% | 552 |
|
2022
Q1 | $2.63M | Buy |
10,086
+613
| +6% | +$160K | 0.02% | 566 |
|
2021
Q4 | $2.08M | Buy |
9,473
+2,251
| +31% | +$494K | 0.01% | 608 |
|
2021
Q3 | $1.31M | Buy |
7,222
+814
| +13% | +$148K | 0.01% | 762 |
|
2021
Q2 | $1.29M | Sell |
6,408
-11,397
| -64% | -$2.3M | 0.01% | 735 |
|
2021
Q1 | $3.83M | Buy |
17,805
+12,652
| +246% | +$2.72M | 0.03% | 354 |
|
2020
Q4 | $1.22M | Sell |
5,153
-1,651
| -24% | -$390K | 0.02% | 551 |
|
2020
Q3 | $1.85M | Buy |
6,804
+687
| +11% | +$187K | 0.03% | 405 |
|
2020
Q2 | $1.78M | Buy |
6,117
+4,667
| +322% | +$1.36M | 0.03% | 352 |
|
2020
Q1 | $345K | Sell |
1,450
-47
| -3% | -$11.2K | 0.01% | 766 |
|
2019
Q4 | $328K | Sell |
1,497
-10
| -0.7% | -$2.19K | 0.01% | 882 |
|
2019
Q3 | $255K | Buy |
1,507
+49
| +3% | +$8.29K | 0.01% | 946 |
|
2019
Q2 | $267K | Buy |
1,458
+29
| +2% | +$5.31K | 0.01% | 923 |
|
2019
Q1 | $263K | Buy |
+1,429
| New | +$263K | 0.01% | 868 |
|